Saudi Press

Saudi Arabia and the world
Saturday, Jun 21, 2025

FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use

FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use

Dr. Archana Chatterjee told CNBC on Friday she's "fully supportive" of emergency use authorization for people who are 18 years and older.


Dr. Archana Chatterjee, a member of the FDA advisory panel who voted against recommending Pfizer’s Covid-19 vaccine for emergency use, told CNBC on Friday that her opposition was because she did not believe 16- and 17-year-olds should be included right now.

In a “Squawk Box” interview, Chatterjee said she would have voted “yes” had the question before her been different. “I want to be very clear that I am fully supportive of the emergency use authorization for the use of this vaccine from Pfizer and BioNTech for adults 18 years and older,” said Chatterjee, a pediatric infectious disease specialist who serves as dean of the Chicago Medical School.

The FDA committee recommended emergency authorization of the vaccine for people who are 16 years old and older.

In addition to Chatterjee, three other members of a Food and Drug Administration advisory panel on Thursday voted against recommending U.S.-based Pfizer and German partner BioNTech’s vaccine for emergency use. One member abstained from voting, while 17 voted in favor of a recommendation.

The decision from the group of outside experts is nonbinding, but on Friday, FDA Commissioner Stephen Hahn said in a statement that the agency was working “rapidly” toward finalizing emergency use authorization.

The vaccine from Pfizer and BioNTech would be the first to receive regulatory clearance in the United States. It has already been granted approvals by health officials in the United Kingdom and Canada.

Chatterjee noted that the vaccine was 95% effective in preventing Covid-19 in clinical trials while also demonstrating a “really good safety profile overall.” She added, “I think that we were pleasantly surprised to see that this vaccine has such good efficacy in tens of thousands of participants that were included in the trial.”

While commending Pfizer and BioNTech for including people under age 18 in the trials, she stressed that she would like to have seen additional data before recommending more individuals in the group receive it.


Dr. Ofer Levy, director of the Precision Vaccines Program at Boston Children’s Hospital, was among the 17 outside experts who voted in favor of recommending the vaccine for emergency use. He told CNBC a “rigorous” safety review process took place, including for 16- and 17-year-olds.

“There was no particularly different safety signal for them as the older individuals so the majority of the committee members felt comfortable voting ‘yes,’” Levy said Friday on “Worldwide Exchange.”

“Yesterday was a milestone but there is a long road ahead” in the effort to end the coronavirus pandemic, Levy added. He pointed to the need for a large supply of Covid-19 vaccines so more people have the opportunity to be vaccinated, both in the U.S. and abroad.

Because doses of the Pfizer-BioNTech vaccine will be limited at first, concerns raised about younger individuals receiving it at this moment are “moot,” contended Dr. Scott Gottlieb, a Pfizer board member and former FDA chief. Health-care workers and residents of long-term care facilities are set to be first in line to get the shots.

“This vaccine isn’t going to be eligible for 16- and-17 year-olds for quite some time ... and probably until it gets fully licensed at some point, hopefully if everything goes well, in the spring and summertime,” Gottlieb said on “Squawk Box.”

The FDA’s advisory panel is set to meet next week on whether to recommend emergency use of Moderna’s Covid’s vaccine, which like Pfizer’s requires two shots and employs a new approach to inoculations that uses genetic material to provoke an immune response.


Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
Trump's Anti-War Stance Tested Amid Israel-Iran Conflict
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
Wreck of $17 Billion San José Galleon Identified Off Colombia After 300 Years
Iran Launches Extensive Missile Attack on Israel Following Israeli Strikes on Nuclear Sites
Israel Issues Ultimatum to Iran Over Potential Retaliation and Nuclear Facilities
Black Box Recovered from Air India Crash Site
Coinbase CEO Warns Bitcoin Could Supplant US Dollar Amid Mounting National Debt
Trump to Iran: Make a Deal — Sign or Die
Operation "Like a Lion": Israel Strikes Iran in Unprecedented Offensive
Israel Launches 'Operation Rising Lion' Targeting Iranian Nuclear and Military Sites
Israeli Forces Intercept Gaza-Bound Aid Vessel Carrying Greta Thunberg
IMF Warns of Severe Global Trade War Impacts on Emerging Markets
Syria to Reconnect to Global Economy After 14 Years of Isolation
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Global News Roundup: From Ukraine's strategic military strikes and Russia's demands and Tensions Escalate in Ukraine, to serious legal issues faced by Britons in Bali and Trump's media criticism, the latest developments highlight a turbulent landscape
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
Iran Warns Europe Against Politicizing UN Nuclear Report
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
EU Central Bank Pushes to Replace US Dollar with Euro as World’s Main Currency
European and Arab Ministers Convene in Madrid to Address Gaza Conflict
U.S. Health Secretary Ends Select COVID-19 Vaccine Recommendations
Trump Warns Putin Is 'Playing with Fire' Amid Escalating Ukraine Conflict
India and Pakistan Engage Trump-Linked Lobbyists to Influence U.S. Policy
U.S. Halts New Student Visa Interviews Amid Enhanced Security Measures
Trump Administration Cancels $100 Million in Federal Contracts with Harvard
SpaceX Starship Test Flight Ends in Failure, Mars Mission Timeline Uncertain
King Charles Affirms Canadian Sovereignty Amid U.S. Statehood Pressure
×